University of Denver

Digital Commons @ DU
Electronic Theses and Dissertations

Graduate Studies

1-1-2011

MicroRNAs 9a, 9b, 9c and 315 Regulate Expression of a Reporter
for the Neuronal Microtubule-Associated Protein Futsch/MAP1B
Leslie M. Rozeboom
University of Denver

Follow this and additional works at: https://digitalcommons.du.edu/etd
Part of the Biology Commons, and the Neuroscience and Neurobiology Commons

Recommended Citation
Rozeboom, Leslie M., "MicroRNAs 9a, 9b, 9c and 315 Regulate Expression of a Reporter for the Neuronal
Microtubule-Associated Protein Futsch/MAP1B" (2011). Electronic Theses and Dissertations. 914.
https://digitalcommons.du.edu/etd/914

This Thesis is brought to you for free and open access by the Graduate Studies at Digital Commons @ DU. It has
been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital
Commons @ DU. For more information, please contact jennifer.cox@du.edu,dig-commons@du.edu.

MICRORNAS 9A, 9B, 9C AND 315 REGULATE EXPRESSION OF A REPORTER
FOR THE NEURONAL MICROTUBULE-ASSOCIATED PROTEIN
FUTSCH/MAP1B
__________
A Thesis
Presented to
the Faculty of Natural Sciences and Mathematics
University of Denver
__________
In Partial Fulfillment
of the Requirements for the Degree
Master of Science
__________

by
Leslie M. Rozeboom
August 2011
Advisor: Scott A. Barbee

Author: Leslie M. Rozeboom
Title: MICRORNAS 9A, 9B, 9C AND 315 REGULATE EXPRESSION OF A
REPORTER FOR THE NEURONAL MICROTUBULE-ASSOCIATED PROTEIN
FUTSCH/MAP1B
Advisor: Scott A. Barbee
Degree Date: August 2011
Abstract
Fragile X syndrome (FXS) is the most common form of inherited mental
retardation in humans. FXS is caused by loss of the Fragile X Mental Retardation Protein
(FMRP), an important regulator of neuronal mRNA translation.

Patients with FXS

display cognitive deficits including memory problems. Protein synthesis-dependent longterm changes in synaptic plasticity are involved in the establishment and maintenance of
long-term memory. One prevalent theory of FXS pathology predicts that FMRP is
required to negatively regulate the translation of important mRNAs at the synapse. We
are investigating microRNAs (miRNAs) as a potential regulator of synaptic FMRPregulated mRNAs that have previously been described as being crucial to the process of
synaptic plasticity.
The general hypothesis underlying this thesis is that FMRP may negatively
regulate the expression of futsch (the Drosophila homologue of the microtubuleassociated protein gene MAP1B) via the miRNA pathway. The first step we took in
testing this hypothesis was to confirm that futsch is subject to miRNA-mediated
translational control. Using in silico target analysis, we predicted that several neuronally
expressed miRNAs target the futsch mRNA 3’UTR and repress expression of Futsch
protein. Then, using an in vitro luciferase reporter system, we showed that miR-315 and
members of the miR-9 family selectively down-regulated futsch reporter translation. We
ii

have confirmed by site- directed mutagenesis that the miRNA interaction with the futsch
3’UTR is specific to the miRNA seed region binding site. Interestingly, reduction of
FMRP levels by RNAi had no effect on futsch 3’UTR reporter expression. Together,
these data suggest regulation of futsch expression by the miRNA pathway might be
independent of FMRP activity. However, additional experiments need to be completed to
confirm these preliminary results.
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Chapter One: Introduction
1.1 Overview
Fragile X syndrome (FXS) is the most common form of inherited mental
retardation in humans, and is a major genetic cause of autism (Bassell and Warren, 2008).
It has an estimated incidence of 1 in 4,000 men and 1 in 8,000 women (Warren et al.,
1991). FXS is caused by loss of the Fragile X Mental Retardation Protein (FMRP), an
important regulator of neuronal mRNA translation. The absence of FMRP is due to the
transcriptional inactivation of the fragile X mental retardation 1 (FMR1) gene, which
results from an unstable expansion of a CGG trinucleotide repeat in its 5’ untranslated
region (UTR) (Jin and Warren, 2003). Transcriptional repression of the FMR1 gene
occurs when the CpG islands and the CGG repeats are hypermethylated. A current
model postulates that FMRP regulates mRNA transport and local protein synthesis in
response to activated metabotropic glutamate receptors (mGluRs) (Figure 1; Jin et al.,
2004b). The activation of group I mGluRs (mGluR1 and mGluR5) stimulates the
synthesis of FMRP in synapses (Figure 1; Weiler et al., 1997). It is believed that one
major function of FMRP at the cell synapse is to offset local translation of specific
mRNAs following mGluR stimulation (Krueger et al., 2011). While a significant amount
of progress has been made towards understanding these processes, there are still several
important questions that need to be addressed. First, which specific mRNAs are being
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FIGURE 1. Model for mRNA regulation by FMRP. After translation, FMRP
dimerizes in the cytoplasm then is imported to the nucleus where it forms a messenger
ribonucleoprotein (mRNP) complex with specific hairpin structured RNA transcripts and
other proteins. The FMRP–mRNP complex is then transported to the cytoplasm where it
can either associate directly with the polyribosomes or interact with the RNA-induced
silencing complex (RISC). The FMRP-mRNP complexes can regulate protein synthesis
in the cell body, or they can be transported to the dendrites to regulate local protein
synthesis upon metabotropic glutamate stimulation. In the mGluR theory of FXS
pathogenesis, one essential function of FMRP is to repress the expression of specific
mRNAs at the synapse. Most of these mRNAs remain uncharacterized. FMRP=green
hexagon, Ribosomes = purple ovals, RISC = red star, newly synthesized protein = string
of blue circles, mGluR= orange oval. Figure adapted from Jin et al. (2004b).
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regulated by FMRP? Second, how does FMRP regulate the expression of these target
mRNAs? The second question will be addressed in the hypothesis outlined below.

1.2 Genetics of FXS
FXS has an unusual genetic inheritance pattern referred to as the Sherman
Paradox. In the 1980s, Sherman showed that nonpenetrant male carriers exist in fragile X
syndrome families, which is an unusual observation for an X-linked disorder. Symptomfree (nonpenetrant) males can transmit their alleles to nonpenetrant daughters who can
then bear symptomatic (penetrant) male offspring (Sherman et al., 1985). Affected
individuals display a phenotype of a “fragile site” or unstaining gap on the metaphase X
chromosome that segregates with the mutant gene (Penagarikano et al., 1991). FMR1, the
gene responsible for FXS, has been mapped to the fragile site on the X chromosome.
Cloned and first identified in 1991, (Verkerk et al., 1991), it was one of the first
trinucleotide repeats linked to a disease. Interestingly, unlike most disease-associated
trinucleotide repeats, the expansion responsible for FXS occurs in a non-coding region of
the gene (in this case, the 5’UTR of FMR1) (Jin et al., 2004b).

1.3 Polynucleotide Expansions in FMR1
An extreme CGG polynucleotide expansion (>200 repeats) is the causative
mutation in 99% of individuals with FXS (Jin et al., 2004b). However, there is a great
deal of variation in the number of CGG repeats in the 5’UTR of FMR1 in humans (Figure
2). Three categories of people have been identified. Most people have “normal” alleles
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FIGURE 2. Schematic representation of the FMR1 gene and CGG polynucleotide
expansions in the FMR1 5’UTR. There are 17 exons in the FMR1 gene that can
undergo alternative splicing. Expansions of the CGG repeat greater than 200 are
characterized as a “full mutation”, expansions with fewer than 200 CGG repeats but
significantly more than average are characterized as a “premutation”. Premutation alleles
can lead to the development of FXTAS (males) or FXPOI (females) later in life. Full
mutation alleles are the primary cause of FXS. Figure adapted from Bassell et al. (2008).
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containing between 6 and 54 repeats, with 30 repeats being most common. Normal
FMR1 alleles are usually transmitted stably, but will occasionally gain or lose a few
repeats. This variation leads to a pool of people with elevated repeat numbers that could
eventually evolve premutations (Penagarikano et al., 2007). A second class of people has
“premutation” alleles with significantly more than average, but fewer than 200, CGG
repeats.

Premutation alleles are unstable and tend to expand when maternally

transmitted.

Longer premutation alleles are more unstable than shorter premutation

alleles, and more likely to lead to full mutation alleles in offspring than shorter ones. The
length of the repeat in a premutation allele in a female is correlative to the likelihood of
expansion to a full, symptomatic, mutation in her offspring. As a male does not pass an
X chromosome to his sons, the male’s FMR1 allelic status does not affect the likelihood
of FXS in his offspring. People carrying premutation alleles are usually asymptomatic,
but in some cases will develop problems later in life including fragile X-associated
tremor ataxia syndrome (FXTAS) and premature ovarian failure (FXPOI). A third class
of people has “full mutation” (>200 and often >500 repeats) alleles. In these people, FXS
is always penetrant in males and is 50% penetrant in females.

1.4 FXS Pathology
Morphologically, cerebral cortical autopsies from FXS patients show abnormal
dendritic spine morphology (Irwin et al., 2001).

Behaviorally, the most prominent

phenotype of FXS in humans is intellectual disability; patients will have IQ values
generally between 20 and 70. Short-term memory for complex information, visuospatial
5

skills and speech are particularly affected. Speech development is often delayed in FXS
children.

Some patients also display hyperactivity, hypersensitivity toward sensory

stimuli and attention deficit disorder (Penagarikano et al., 2007). Interestingly, between
15% and 50% of FXS patients display autistic behavior (poor visual contact, tactile
defensiveness, repetitive behaviors). FXTAS and autism share some symptoms with
FXS, which may indicate that related synaptic development problems may underlie all
three syndromes. It has been proposed that mutations in FMR1 may be the most common
single-gene cause of autism.

1.5 FMRP
In order to understand the pathogenesis of FXS and develop therapeutic strategies,
we must understand its underlying cause: the loss of function of FMRP. While FMRP is
widely expressed in fetal and adult tissues, its expression is most pronounced in the brain
and testis, where major FXS symptoms (mental retardation and macroorchidism)
manifest (Warren and Nelson, 1994). FMRP is a selective RNA-binding protein that can
form a messenger ribonucleoprotein (mRNP) with polyribosomes (Ashley et al., 1993).
FMRP has been shown to associate with actively translating ribosomes (Jin and Warren,
2003). Moreover, a current model postulates that FMRP is involved in synaptic plasticity
because it regulates mRNA transport and local synaptic protein synthesis (Figure 1; Jin et
al., 2004b). FMRP is thought to bind to approximately 4 percent of fetal human brain
mRNAs in vitro (Brown et al., 1998). One theory of how FMRP regulates mRNA
translation is that it recognizes its target mRNAs directly.
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Alternatively, there is

evidence that FMRP may require accessory factors such as a miRNA-containing RISC
(miRISC) in order to bind to and regulate target mRNAs (Figure 3; Li and Jin, 2009).
The human FMR1 gene is approximately 38 kilobases long and contains 17 exons
(Figure 2; Ashley et al., 1993). Through alternative splicing, the human FMR1 gene can
generate at least 12 different proteins between 67 and 80 kDa (Devys et al., 1993). The
FMRP protein has two sequence motifs characteristic of RNA binding proteins. First, a
cluster of arginine and glycine residues known as the RGG box has been shown to bind to
a G quartet structure formed by some mRNAs (Darnell et al., 2001). The G quartet is an
RNA loop structure with a planar conformation of four guanine residues that is stabilized
by Hoodsteen base pairs (Figure 4). Several of these planar quartets can stack to form the
characteristic quadraplex recognized by FMRP. Second, FMRP has two heterogeneous
nuclear ribonucleoprotein K homology (KH) domains. These are shown to bind a RNA
tertiary structure known as a “kissing complex” (Figure 4; Darnell et al., 1993).
FMRP is also believed to interact with target RNAs through several other
conserved regulatory elements. FMRP has been found to bind RNA ligands containing U
rich sequences of 5-23 bases of repeating U pentamers (Figure 4; Chen et al., 2003).
There is also controversial evidence that FMRP can interact with some target mRNAs via
the novel noncoding BC1 RNA (Zalfa et al., 2005; Iacoangeli et al., 2007). Of particular
interest to work presented in this thesis, FMRP has been found to have both biochemical
and genetic interactions with components of the miRNA pathway (Zhang et al., 2001;
Ishizuka et al., 2002; Jin et al., 2004a). Thus, FMRP may regulate neuronal translation
via or in concert with miRNAs (Menon et al., 2008).
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FIGURE 3. Model of miRNA- and FMRP-mediated mRNA regulation. Mature
miRNAs are loaded onto the RISC and bind to target mRNAs through complementary
base pairing. There are several potential mechanisms of down- regulation of mRNA
expression by miRNA expression. The miRISC could bind the mRNA directly and target
it for degradation or translational repression. Alternatively, FMRP may associate with
the miRISC and facilitate binding to target mRNAs. Cooperative action between FMRP
and the miRISC could then direct the mRNA for decay or translational repression.
Figure adapted from Jin and Li (2009).
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FIGURE 4. Conserved RNA tertiary structures recognized by FMRP. a) G quartet:
an RNA loop structure with a planar conformation of four guanine residues that is
stabilized by Hoodsteen base pairs. Several of these planar quartets can stack to form a G
quadraplex. b) U pentamer: a U rich sequence that forms a characteristic tertiary
structure. and c) Kissing complex: a complex “loop-loop pseudoknot” tertiary structure
(Penagarikano et al., 2007). Figure adapted from Penagarikano et al. (2007).
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1.6 miRNAs
miRNAs are short (~21-22 nucleotides) non-coding regulatory RNAs that
modulate gene expression post-transcriptionally (Li and Jin, 2009). miRNAs downregulate expression of target mRNAs by binding specifically with antisense sequences in
the 3’ UTR, although there is evidence that they can bind to sequences in the 5’ UTR and
protein coding region (Breving et al., 2010). Briefly, miRNAs are transcribed in the
nucleus as primary transcripts (pri-miRNAs) from hundreds to thousands of nucleotides
long. The pri-miRNA forms a secondary hairpin structure that is recognized and cleaved
by the RNAse III enzyme Drosha yielding a precursor RNA of approximately 80
nucleotides. The pre-miRNA is exported to the cytoplasm where it is cleaved by the
RNAse III enzyme Dicer in concert with a dsRNA binding protein into the mature
miRNA. One strand of miRNA is then incorporated into the RNA-induced silencing
complex (RISC) and the other is typically degraded. It is believed that the miRNA
guides the RISC to its target, where a complimentary base pairing between the miRNA
and the target mRNA leads to down-regulation of the target’s expression, either by
translational repression or by mRNA degradation (Figure 5).
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FIGURE 5. General pathway for miRNA biosynthesis. 1) Within the nucleus, the
miRNA gene is transcribed by Polymerase II resulting in a pri-miRNA precursor
averaging from 100’s to 1000’s of nucleotides long. 2) The stem-loop secondary
structures of the pri-miRNA are recognized by the Drosha Microprocessor complex and
cleaved into a ~70 nucleotide long pre-miRNA hairpin structure which is exported from
the nucleus into the cytoplasm by the Exportin-5/Ran-GTP complex. 3) In the
cytoplasm, the pre-miRNA associates with the RNAse-III type enzyme DICER, The
mammalian TAR RNA-binding protein (TRBP; loquacious in Drosophila), and possibly
an Argonaute protein and is cleaved to yield an ~22 nucleotide miRNA duplex. 4) One
strand (termed the “guide” strand) of the mature miRNA associates with the RISC
machinery leading either to translational repression or degradation of the target mRNA.
Figure adapted from Breving et al. (2009).
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1.7 FMRP Interacts with the miRNA Pathway
A current model for FMRP function is that it binds target mRNAs in the
nucleus to form a ribonucleoprotein complex, which is then transported to the dendrites
or spines. At the synapse, FMRP is involved in the control of local protein synthesis via
general and/or miRNA-mediated translational regulation (Bassell and Warren, 2008; Li
and Jin, 2009). Five independent lines of evidence support an interaction between the
FMRP and miRNA pathways. First, in vivo, mammalian FMRP interacts with miRNAs
and components of the miRNA pathway, including Dicer and the mammalian ortholog of
AGO1. Furthermore, RNAs of ~20 and ~80 nucleotides (presumptive miRNAs and
premiRNAs) immunoprecipitate with FMRP (Jin et al., 2004). Second, in Drosophila,
dFMRP interacts biochemically with the functional RISC proteins including dAGO1,
dAGO2 and Dicer (Ishizuka et al., 2002). Moreover, dFmr1 dominantly interacts with
dAgo1 to regulate neuronal development and synaptogenesis (Jin et al., 2004). Third, in
Drosophila, miR-124 interacts with FMRP and controls sensory neuron structure (Xu et
al. 2008). Fourth, rat miR-125b and miR-132 (and others) interact with FMRP and
control hippocampal neuron structure and function (Edbaur et al. 2010). miR-125b
regulates NMDAR expression (Edbaur et al., 2010). Finally, translational control of the
murine postsynaptic density protein 95 (PSD95) by miR-125a has recently been shown to
require FMRP activity, although a biochemical interaction has not yet been reported
(Muddashetty et al., 2011).
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1.8 Futsch/ MAP1B
It has been clearly shown in flies and mammals that FMRP is required for
translational regulation of the microtubule-associated protein, MAP1B, however the
precise mechanism remains unclear (Zhang et al., 2001; Lu et al., 2004). Microtubuleassociated proteins (MAPs) are expressed in eukaryotic cells and bind along the
microtubule lattice. Post-translation, MAP1A and MAP1B are cleaved into light and
heavy chains. Those chains are then assembled (with the separately encoded light chain
3 subunit LC3) into mature complexes (Halpain et al., 2006). Mammalian genomes
usually contain three family members: MAP1A, MAP1B and MAP1S (Halpain et al.,
2006). No obvious ortholog of any MAP1-family protein occurs in Caenorhabditis
elegans or more primitive organisms. The Drosophila genome only contains one MAP1family protein, the homolog of MAP1B, Futsch.
Neurons in FXS patients have more long, thin, immature spines, fewer short
spines, and an overall increased spine density, which suggests impaired synapse
development (Irwin et al., 2001). Similar synaptic abnormalities are observed in Fmr1
knockout (mice and Drosophila) neurons (Comery et al., 1997; Zang et al., 2001).

1.9 miRNA-Mediated Regulation of futsch
The precise details of futsch regulation by FMRP remain unknown. As such,
MAP1B was considered to be a candidate for regulation by both FMRP and the miRNA
pathway. Bearing this in mind, identification of miRNAs that regulate Futsch, and
elucidation of the mechanism by which they do so, would be the first logical step towards
understanding the Futsch/FMRP regulatory pathway. In silico analysis has indicated that
13

specific miRNAs may regulate Futsch. Here, we investigate the role of candidate
miRNAs as a novel regulatory mechanism in the control of Futsch expression.

14

Chapter Two: Method
2.1 RNA Extraction and Analysis by Quantitative Real-Time PCR (qRT-PCR)
Central Nervous System (CNS) tissues, (including ventral ganglia and optic
lobes) were dissected from w1118 wandering 3rd instar larvae in cold HL-3 buffer then
transferred to 700 µl QIAzol Lysis Reagant (Qiagen). CNSs were homogenized with a
TissueRuptor (Qiagen) for 30 seconds at high speed. Homogenate was applied to a
QIAshredder column (Qiagen). After elution and chloroform precipitation, the aqueous
phase was removed and purified using the RNeasy purification kit (Qiagen). RNA was
eluted from RNeasy spin columns with 30µl DEPC treated H20 then flash frozen with
liquid nitrogen and stored at -80°C until analysis.
Quantitative real time PCR (qRT-PCR) was performed “in house” to confirm that
our miRNAs are expressed in the larval CNS using an iQ5 Real-Time PCR detection
system (BioRad). A reverse transcription reaction was performed using the SYBR Green
based miScript miRNA RT-qPCR detection system (Qiagen). The purified RNA was
used in a reverse transcription reaction using the SYBR Green miScript Kit. Mature
miRNAs were converted to cDNA using the miScript Reverse Transcription Kit (Qiagen)
and qRT-PCR done using the miScript SYBR Green PCR Kit (Qiagen). The first-strand
template was used as the template for the quantitative real-time PCR with the provided
universal primer and miScript Primers for mature miR-315, -9a, -9b and -9c (proprietary
sequences designed by and obtained from Qiagen).
15

2.2 miRNA Analysis by miRNA Array
CNS tissues (ventral ganglia and optic lobes) were dissected from w1118
wandering 3rd instar larva in cold HL-3 buffer then transferred to lysis buffer. The RNA
was then purified (following manufacturer’s protocol) with the miRcury RNA isolation
Kit (Exiqon). CNSs were homogenized with a TissueRuptor (Qiagen) for 30 seconds at
high speed. Homogenate was applied to a QIAshredder column (Qiagen). After elution
and chloroform precipitation, the aqueous phase was removed then purified (following
manufacturer’s protocol) with miRCURY RNA isolation kit (RNeasy Mini Spin Kit,
Exiqon). The RNA was eluted from RNeasy spin columns with 30µl DEPC- treated H20.
RNA concentration was determined using a NanoDrop ND-1000 spectrophotometer
(Thermo Fisher Scientific) and RNA was shipped to Exiqon on dry ice for quality control
and miRNA microarray analysis.
Exiqon employed a chip-based hybridization miRNA microarray based on
miRBase 14.0 (http://www.mirbase.org; Kozomara et al., 2011; Griffiths-Jones et al.,
2004; Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008), which at the time
represented 99.3% of known Drosophila miRNAs. The most current database release,
miRBase 17.0 (http://www.mirbase.org; Kozomara et al., 2011; Griffiths-Jones et al.,
2004; Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008) contains a larger number
of miRNAs, so the analysis performed using miRBase 14.0 covers only 62% coverage of
known miRNAs.
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2.3 DNA Constructs
In order to confirm that the miRNAs identified by in silico analysis actually
interact with and down-regulate the target mRNA (futsch), we took advantage of an
established dual luciferase reporter system in S2 cells. The first step was to construct the
necessary vectors to be transfected into the S2 cells.
Futsch firefly luciferase reporter.
For expression in S2 cells, a PCR fragment containing the futsch 3’UTR was
amplified from a BAC vector obtained from the Drosophila Genomics Resource Center
(DGRC) with the upstream primer (5’‐GCCACGGGTCTGTTTATTG‐3’) and the
downstream primer (5’‐ TGACTCTCTGCTCATTCTCGT‐3’).

The futsch 3’UTR was

cloned first into pENTR using the Gateway system (Invitrogen) and then into the
appropriate destination vector (pAc5.1-FLuc2:dPolyA-RFA) by LR recombination. The
expression of the futsch reporter in this vector is driven with a constitutively active
Drosophila actin promoter but is lacking a 3’UTR sequence required for efficient 3’ end
formation.
miRNA expression vectors.
The primary miR-9a sequence was amplified from w1118 larval genomic DNA
using the forward primer (5’‐CACC AATGTCCATGGGGCTAGCGA‐3’) and the reverse
primer (5’‐TGGCCGTAAAGCCAAACTGC‐3’). The primary miR-9b sequence was
amplified from w1118 larval genomic DNA using the forward primer (5’‐ CACC
GCATTGGCTTCTGCAGGTCA–3’)

and
17

the

reverse

primer

(5’‐

GCGAGCATATCTCCAGGGCA ‐3’). The primary miR-9c sequence was amplified from
w1118

larval

genomic

DNA

ATTCCAGAGCATCGCCATCG‐3’)

using
and

the
the

forward
reverse

primer

(5’‐CACC

primer

(5’‐

GATCCCAGGGCAGCTCTGAA‐3’). The primary miR-315 sequence was amplified from
w1118

larval

genomic

DNA

TCAGTGCATTGTGATGCCCA‐3’)

using
and

the
the

forward
reverse

primer

(5’‐CACC

primer

(5’–

AAATCGTCAGCGTTGAGGGG‐ 3’).
The CACC sequence was added to the 5’ end of the forward primers to allow
directional cloning into pENTR.

The primary miRNA sequences were cloned into

pENTR using a TOPO Cloning Reaction (Invitrogen kit for cloning blunt-end PCR
product into an entry vector for the Gateway System). The primary miRNA sequences
were then cloned (using an LR reaction) into pAC5.1-RFA. The expression of the
miRNA is driven with a constitutive Drosophila actin promoter and an SV40 3’UTR is
cloned downstream of the primary miRNA sequence to ensure robust expression.
Renilla luciferase transfection control.
In order to normalize the reporter expression reading results for differences in
transfection efficiency between wells, we used a Renilla luciferase vector. The Renilla
luciferase is similar to firefly luciferase, but is derived from the Renilla reniformis polyp
(known as the “sea pansy”). Renilla luciferase cloned into pAc5.1 (Invitrogen) served as
a transfection control. The expression of the Renilla luciferase protein is driven with a
constitutive actin promoter and contains an SV40 3’UTR cloned downstream of the
primary miRNA sequence to ensure robust expression.
18

Empty expression vector.
In order to control for quantity of DNA input into the S2 co-transfection, the same
vector (pAC5.1-RFA) without any primary miRNA sequence is used in place of the
miRNA expression vector.
NERFIN reporter vector.
The nerfin 3’UTR was amplified from w1118 genomic DNA using the forward
primer (5’–CACC CCATGGCCCACTGAAATCGAGTGAG–3’) and the reverse primer (5’–
CCCTGACAACCCAAAGAGAACCCAACAAG–3’) (Kuzin et al., 2004). The nerfin 3’UTR
was cloned using an LR reaction into the pAc5.1-FLuc2:dPolyA-RFA vector.

All

plasmids were maxi- prepped endotoxin-free (Qiagen).
Site directed mutagenesis of futsch reporter.
In order to confirm that the down-regulation observed in the reporter vector is
specifically due to the miRNA/mRNA interaction in the predicted seed region binding
site, we created versions of the futsch reporter plasmid in which the predicted binding site
is altered.
The core binding regions of miR-9 and miR-315 on the futsch 3’ UTR were
mutagenized using the Phusion Site-Directed Mutagenesis Kit by Thermo Scientific
(product code: F-541). Using the Firefly luciferase futsch 3’UTR reporter vector (“FLuc-F”) as a starting point, we introduced three nucleotide mutations at the miRNA
binding sites.

We will refer to these mutagenized plasmids as “FLucF9mut” and

“FLucF315mut” respectively.
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In order to create the FLucF9mut reporter plasmid, the F-Luc-F plasmid was PCR
amplified

with

the

forward

5’

phosphorylated

primer

(5’-

TTAGTAATCCTTGGATCAAAATAGTTTT-3’) and the reverse 5’ phosphorylated
primer (5’-GCAAGGTAGCTTGACGTTATGCAA-3’) according to the manufacturer’s
protocol. The PCR product was circularized with Quick T4 DNA Ligase. Plasmids were
transformed into TOPO10 competent E. coli cells. Mini-prepped DNA was sequenced
through the mutation to confirm the mutation was successful.
In order to create the FLucF315mut reporter plasmid, the F-Luc-F plasmid was
PCR

amplified

with

the

forward

5’

phosphorylated

primer

(5’-

TTAGTAATCCAAAGATAGCAATAGTTTT-3’) and the reverse 5’ phosphorylated
primer (5’-GCAAGGTAGCTTGACGTTATGCAA-3’) according to the manufacturer’s
protocol. The PCR product was circularized with Quick T4 DNA Ligase. Plasmids were
transformed into TOPO10 competent E. coli cells. Mini-prepped DNA was sequenced
through the mutation to confirm the mutation was successful.
As a result of the site-directed mutagenesis, in the “FLuc315mut” reporter
plasmid three base pairs within miR-315’s binding site were mutated from CAA to AGC.
In the other, “FLucF9mut” three base pairs within the seed region binding site (common
to all three members, miR-9a, miR-9b and miR-9c) were mutated from AAA to TTG.
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2.4 S2 Cells
Drosophila S2 cells were maintained in suspension culture in 250 ml Suspension
Culture Flasks with vent caps (Celltreat cat #229520). Cells were maintained and
experiments were performed in Complete Schneider’s Drosophila Medium (89%
Schneider’s Drosophila Medium (1X), (liquid + L-Glutamine. Gibco cat #11720): 10%
Fetal Bovine Serum (Certified, Gibco Cat #10082): 1% Penicillin-Streptomycin, (liquid,
prepared with 5,000 units/mL Penicillin G sodium and 5,000 µg/mL Streptomycin sulfate
in 0.85% saline, Gibco cat # 15070). Complete media was filter sterilized with Corning
500ml Filter System 0.22µm PES 431097 and stored at 6° Celsius.
Transfections.
S2 cells were transfected in six-well plates (2x106 cells/well) using Effectene
transfection reagent (Qiagen). All transfections were performed in triplicate (or 3
“biological replicates”). The transfection mixtures contained 0.1µg of firefly luciferase
(F-Luc) reporter plasmid, 0.4µg of the Renilla transfection control, and 0.2µg of either
plasmid expressing the miRNA primary transcripts or the pAC5.1-RFA (empty) vector
(Zekri et al., 2009).
Cells were split the day before transfection to ensure that cells were in an
exponential growth phase. On the day of transfection cells were vigorously resuspended,
taking care to wash bottom of flask vigorously to dislodge any semi-adherent cells.
Concentration of cells was determined using an Improved Neubauer haemocytometer
Bright Line Counting Chamber and inverted microscope. Volume of cell suspension to
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be used (2x106 cells /well to be transfected) was calculated. Cells were spun down, and
media decanted. Cells were washed (resuspended in 1xPBS, spun down, PBS decanted)
then resuspended in an appropriate volume of Complete media (1.6ml/well to be
transfected). 1.6 ml cell suspension was seeded into each well (Costar 6 well, Corning
CellBIND Surface cat# 3335). DNA (total of 0.7µg) was diluted in Buffer EC to a
volume of 100µl/well. For each well, a mixture of 0.1µg FLuc-F or FLucmiRmut, 0.4µg
R-Luc (Renilla luciferase transfection control vector), and 0.2µg miRNA expression or
empty vector was used. All plasmids had been maxi prepped endotoxin free (Qiagen
Endotoxin Free Maxi Prep Kit). 5.6 µl Enhancer was added to diluted DNA. Mixture
was vortexed for 1 second. Mixture was incubated at room temperature for 3 minutes.
25µl of Effectene reagent was added to mixture and mixture was vortexed for 10 seconds
then incubated at room temperature for 7 minutes. 1 ml complete media was added to
DNA mixture and mixed by pipetting up and down. Solution was added drop-wise to
wells containing cells, while gently swirling plate.

Cells were incubated for

approximately 72 hours at 25° Celsius.
Passive lysis.
Cells were washed by very gently removing media from the cells with a transfer
pipet. Enough PBS to cover the film of cells adhered to the bottom of the well was
gently applied then removed. 500µl of 1x Passive Lysis Buffer (prepared in nanopureH20 with the 5x Passive Lysis Buffer provided) was applied to washed cells (still adhered
to bottom of well). Cells were incubated 15 minutes at room temperature on a shaker set
at 140 rpm. Cell lysates were transferred to microfuge tubes.
22

2.5 Luciferase Assays
In order to quantitatively assay changes in Futsch expression, we utilized a dualluciferase reporter system (Promega). In each experiment, firefly and Renilla luciferase
activities were measured 3 days after transfection. Three samples (technical replicates)
were measured from each triplicate (biological replicate) transfection. Firefly and Renilla
luciferase luminescence values were measured in a 96 Well, Flat Bottom, Non-treated,
White Polystyrene (Corning cat# 3912) assay plate using a BIO-TEK Synergy HT plate
reader. Reagents Luciferase Assay Reagent II and Stop and Glow solution were prepared
following manufactures instructions. 20µl of cell lysate was added to each well, then
100µl LARII reagent was dispensed into each well. Firefly luminescence measurement
was taken with sensitivity set to 100 (s=100). 100µl Stop and Glo reagent was added to
each well then Renilla luminescence level was measured (s=100).

2.6 Knock-down of dFMRP
In order to investigate if the down-regulation effect observed is dependent on
FMRP, we knocked down FMRP using RNAi.
Creation of dsdFMR1 RNA.
A segment of the dFMR1 coding sequence was amplified from LD09557 plasmid
(obtained from the DGRC) using the forward primer (5’–CGTGCCCGAGAGTATGAAAT‐
3’) and the reverse primer (5’–ATTGTGCGCTGAAACTCCTT‐3’). The PCR product
was purified using StrataPrep PCR purification kit. The purified PCR product was
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ligated into pPCR‐Script Amp SK+1 cloning vector and transfected into XL10‐Gold
cells according to the manufacturer’s protocol.

The dFMR1 pPCR plasmid was

amplified and extracted from XL10- Gold cells. Following manufacturer’s protocol,
dsRNA was amplified as separate strands from dFMR1 pPCR using T3 and T7
Megascript kits. Separate RNA strands were annealed by combining equal quantities of
each strand in a microfuge tube which was placed in boiling water and allowed to cool.
dsRNA (2 micrograms/well) and reporter vectors were co-transfected into S2 cells
according to the protocol published by Rio et al. (2011). Luciferase reporter experiments
were conducted essentially as described above in section 2.5. An aliquot of the cell
lysate was flash frozen on liquid N2 for Western analysis of FMRP levels.

2.7 Western Blot of dFMR1 Knock-down
After 72 hours of incubation, S2 cells were lysed and an aliquot run on a
polyacrylamide gel then transferred to a membrane.

After blocking, the primary

antibodies rabbit anti GAPDH (1:500 concentration) and mouse anti FMRP (6A15)
(1:2,500 concentration) were applied. After an over-night incubation and washing, antimouse HRP and anti-rabbit HRP secondary antibodies (both at 1:10,000 concentration)
were applied for two hours. Membrane was washed, HRP developing solution applied,
and membrane was exposed to film for analysis.
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Chapter Three: Results
3.1 miR-315 and the miR-9 Family are Predicted to Bind to the futsch 3’UTR
To address the question of whether or not futsch expression is regulated by
miRNAs, we first performed in silico analysis of the futsch 3’UTR sequence using the
TargetScanFly target prediction algorithm (http://www.targetscan.org; Release 5.1
Friedman, et al. 2009; Grimson, et al. 2007; Lewis, et al. 2005). TargetScanFly predicts
targets by analyzing sequence complementation between the miRNA and potential
mRNA targets, most importantly sequence conservation in the interaction with the “seed
region” of the miRNA (nucleotides 2-9 from the 5’ end). TargetScanFly compares the
sequences of potential miRNA/mRNA target interactions amongst 10+ Drosophila
species, and ranks those with high conservation to likely be most valid.
Typically, a miRNA binds to a complementary sequence in an mRNA’s 3’UTR,
leading to the regulation of that mRNA. For the interaction to be effective, it is necessary
for part of the miRNA known as the “seed region” (6-8 nucleotides long, typically close
to the miRNA’s 5’UTR) to be a perfect match to the mRNA.

The miRNA can still

control expression if there are mismatches between it and its target mRNA if those
mismatches are outside of the seed region. If the complementary match between the
miRNA and its target mRNA are not perfect within the seed region, the over-expression
of the miRNA should not down-regulate expression of the target mRNA (Doench and
Sharp, 2004).
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We queried the futsch 3’UTR and found that six miRNAs were predicted to bind
the futsch mRNA 3’UTR, including the three members of the miR-9 family (9a, 9b, 9c),
miR-315, miR-963, and miR-976 (Figure 6).
miRNAs with similar sequences.

A miRNA family consists of several

These miRNAs have identical seed regions with

identical and overlapping predicted mRNA binding sites.

miR-315 has a second

predicted binding site in Drosophila that is less conserved between fly species. The
sequences of the miRNAs of interest as reported by miRBase (http://www.mirbase.org;
Kozomara et al., 2011, Griffiths-Jones et al., 2004; Griffiths-Jones et al., 2006; GriffithsJones et al., 2008) of interest are shown in Figure 6.

3.2 miR-315 and the miR-9 Family are Expressed in the Drosophila Larval CNS
We next asked whether these miRNAs of interest are expressed in the larval CNS.
We found, both by a miRNA microarray analysis and by quantitative real-time PCR
(qRT-PCR), that only miR-9a, -b, -c and miR-315 are expressed in the larval CNS.
(Appendix A; data not shown).
First, we purified RNA from control larval Drosophila CNSs (ventral ganglia and
optic lobes) then sent samples for locked nucleic acid (LNA) miRNA microarray analysis
(Exiqon). At the time of our analysis, we found that of the 148 miRNAs known to be
expressed in adult Drosophila melanogaster (miRBase 11.0; 99.3% of known miRNAs)
79 were expressed in the CNS (Appendix A). Since then, updated databases have been
released, the most current being miRBase 17.0. With the latest release, our screening
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represents 62% of known miRNAs. The microRNAs miR-315, -9a, -9b, and -9c were
found to be among the set expressed in the larval CNS (Appendix A).

27

FIGURE 6. futsch is predicted to be regulated by 6 miRNAs. miR-9a, - 9b and -9c
are from the same “family” meaning that they have identical, overlapping seed regions.
miR-315 is predicted to bind to two places on the Drosophila futsch 3’UTR, and miR963 and -976 are each predicted to bind to single sites (TargetScanFly, release 5.1).
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in our analysis, miR-976 and miR-963 were not among those expressed in the larval
CNS.
Next, we sought to confirm that these miRNAs were expressed in the larval CNS
using qRT-PCR. We performed qRT-PCR analysis on control (w1118) Drosophila larval
CNSs. We confirmed that miR-315 as well as the miR-9 family is expressed in the larval
CNS (data not shown). Together with the array results, these data demonstrate that miR315 and the miR-9 family are expressed in the Drosophila larval CNS.

3.3 miR-315 and the miR-9 Family Repress Expression of a futsch Reporter
We next sought to demonstrate that these miRNAs repress Futsch translation as
predicted by our in silico target analysis. To determine if the futsch 3’UTR is a true
target of miRNAs -9a/b/c and -315, we used a Drosophila in vitro S2 cell system using a
dual luciferase reporter assay (Zekri et al., 2009). A firefly luciferase reporter (F-Luc)
with the 3’untranslated region (UTR) of the futsch mRNA (F-LucF) was co-expressed
with a miRNA expression vector and a Renilla luciferase (R-Luc) transfection control
(Figure 7).
Before we could test our primary hypothesis, we needed to confirm that the S2
reporter system worked in our hands. To do this, we co-transfected S2 cells with a nerfin
reporter vector, the Renilla luciferase control vector, and the miR-9b expression vector.
nerfin has been previously shown by others to be down-regulated by miR-9b using a
similar assay (Zekri et al., 2009). We observed a 75.7% down regulation of the nerfin F-
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FIGURE 7. Diagrams of experimental plasmid constructs. Drosophila S2 cells were
co-transfected with three vectors: a primary miRNA expression vector, a Renilla
luciferase (R-Luc) transfection control vector and a firefly luciferase (F-Luc) reporter
vector in which the firefly luciferase gene’s expression is under regulation of the 3’UTR
sequence of interest. An endogenous actin promoter drives all three plasmids. The SV40
3’UTR attached to R-Luc and the primary miRNA sequences provides a strong poly (A)
signal to ensure high levels of translation. The reporter vector includes the endogenous
poly (A) signal within the reporter 3’UTR.
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Luc reporter (Figure 8), consistent with published results. This indicates that the S2
reporter expression assay works in our hands.
In order to address our primary question of whether expression of our miRNAs of
interest down-regulates futsch expression, we then co-transfected S2 cells with three
vectors: the luciferase futsch expression reporter vector, the Renilla transfection control,
and each of the miRNA (or empty) expression vector individually (Figure 7).
As we hypothesized, we found that co-expression of these miRNAs does in fact
decrease expression of the futsch reporter (Figure 9).

miR-315 over-expression

demonstrated the most profound repression of futsch reporter expression (82.2%,
p<0.0006).

Each of the miR-9 family miRNAs down-regulated the futsch reporter

expression to a lesser, but still statistically significant, extent. miR-9a over-expression
reduced futsch reporter levels by 62.3% (p<0.002). miR-9b over-expression reduced
futsch reporter levels by 58.3% (p<0.0025). miR-9c over-expression reduced futsch
reporter levels by 41.6% (p<0.011). These experiments have each been repeated, with
consistent results. While these data indicate that futsch reporter expression is controlled
by each of these miRNAs, it is unclear whether this regulation is due to translational
repression or targeting of the mRNA for degradation.
addressed in future experiments.
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This question needs to be

FIGURE 8. Over-expression of miR-9b suppresses expression of the F-Luc-Nerfin
reporter. S2 cells were transfected with a mixture of three plasmids: the F-Luc-Nerfin
reporter, another expressing the miR-9b primary transcript, and the third expressing
Renilla luciferase. Firefly luciferase activity was normalized to that of Renilla
Luciferase. Mean values of 3 technical replicates for a single biological replicate.
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FIGURE 9. Over-expression of miR-9a, -9b and -9c and -315 suppress expression
of the F-Luc-Futsch reporter. S2 cells were transfected with a mixture of three
plasmids: the F-Luc reporter, another expressing the miRNA primary transcript or the
empty vector, and the third expressing Renilla luciferase. Firefly luciferase activity was
normalized to that of Renilla luciferase and then to the empty vector control. Mean
values ± standard error from three biological replicates. * = p<0.05; ** = p<0.005
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FIGURE 10. Two new futsch reporter vectors created using site directed
mutagenesis. (A) In order to create “FLuc315mut” we mutated three base pairs within
miR-315’s binding site from CAA to AGC. (B) In order to create “FLuc9mut” we
mutated three base pairs within the seed region-binding site (common to all three
members, miR-9a, miR-9b and miR-9c) from AAA to TTG.
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3.4 Repression of futsch Reporter Expression is Specific to the miRNA Binding Sites
in its 3’UTR
We next sought to confirm that the repression response was caused specifically by
the miRNA/futsch 3’UTR interaction.

To address this issue, we used site-directed

mutagenesis to mutate the central seed region binding sites for each of the miRNAs in the
futsch 3’UTR (Figure 10).
We identified the seed region binding sites for the miR-9 family and miR-315
using TargetScanFly (Figure 10; http://www.targetscan.org; Release 5.1 Friedman, et al.,
2009; Grimson, et al., 2007; Lewis, et al., 2005). Members of the miR-9 family share the
same seed region binding site. While the entire predicted binding sites for miRNAs 9a/b/c and -315 partially overlap, they do not share the same seed regions. Bearing this
in mind, we then generated two new futsch reporter vectors using site-directed
mutagenesis.

In one, “FLuc315mut”, we mutated three base pairs within miR-315

binding site from CAA to AGC (Figure 10A). In the other, “FLuc9mut” we mutated
three base pairs within the seed region binding site from AAA to TTG (Figure 10B).
We essentially repeated the experiments outlined above in Figure 9 except used
the appropriate mutagenized futsch 3’UTR reporter vector. In each case, we found that
the miRNA-mediated repression of Futsch expression is relieved when the miRNA
binding site on the futsch 3’UTR is mutated to prevent miRNA binding (Figures 11-14).
Interestingly, while examining miRNA repression, we observed several instances where
miRNA-9a and miR-9c over-expression actually up-regulated the expression of the
mutated futsch reporter (Figures 11 and 13).
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FIGURE 11. Over-expression of miR-9a suppresses expression of the F-Luc-Futsch
reporter, but does not suppress expression of the miR-9 binding site mutagenized FLuc-Futsch reporter. S2 cells were transfected with a mixture of three plasmids: the FLuc reporter, another expressing the miRNA primary transcript or the empty vector, and
the third expressing Renilla luciferase. Firefly luciferase activity was normalized to that
of Renilla luciferase, and normalized values of F-Luc were then normalized to the
reporter plasmid without miRNA. Mean values ± standard error from three biological
replicates. * = p< 0.05 ** p= <0.005
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FIGURE 12. Over-expression of miR-9b suppresses expression of the F-Luc-Futsch
reporter, but does not suppress expression of the miR-9 binding site mutagenized FLuc-Futsch reporter. S2 cells were transfected with a mixture of three plasmids: the FLuc-Futsch reporter, another expressing the miRNA primary transcript or the empty
vector, and the third expressing Renilla luciferase. Firefly luciferase activity was
normalized to that of Renilla luciferase, and normalized values of F-Luc were then
normalized to the reporter plasmid without miRNA. Mean values ± standard deviations
from three biological replicates. * = p<0.005.
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FIGURE 13. Over-expression of miR-9c suppresses expression of the F-Luc-Futsch
reporter, but does not suppress expression of the miR-9 binding site mutagenized FLuc-Futsch reporter. S2 cells were transfected with a mixture of three plasmids: the FLuc-Futsch reporter, another expressing the miRNA primary transcript or the empty
vector, and the third expressing Renilla luciferase Firefly luciferase activity was
normalized to that of Renilla luciferase, and normalized values of F-Luc were then
normalized to the reporter plasmid without miRNA. Mean values ± standard error from
three biological replicates. * = p<0.005
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FIGURE 14. Over-expression of miR-315 suppresses expression of the F-Luc-Futsch
reporter, but does not suppress expression of the miR-315 binding site mutagenized
F-Luc-Futsch reporter. S2 cells were transfected with a mixture of three plasmids: the
F-Luc-Futsch reporter, another expressing the miRNA primary transcript or the empty
vector, and the third expressing Renilla luciferase. Firefly luciferase activity was
normalized to that of Renilla luciferase, and normalized values of F-Luc were then
normalized to the reporter plasmid without miRNA. Mean values ± standard error from
three biological replicates. * = p<0.005

39

3.5 FMRP May Not Regulate futsch Expression Through Elements in the 3’UTR
Next, we wanted to determine whether miRNA-mediated repression of the futsch
reporter might be mediated by FMRP.

However, we first wanted to determine if

Drosophila FMR1 could alone regulate reporter expression. In order to address this
question, we knocked-down dFMR1 expression in S2 cells using RNA interference
(RNAi) and confirmed the success of the knock-down by Western Blot (Figure 15). We
assayed the same S2 cell lysates from the FMR1 RNAi cells using the dual luciferase
system. Interestingly, we found that knock down of FMR1 does not affect levels of our
futsch expression reporter (Figure 16). Based on these observations, we elected to not
pursue additional experiments addressing FMRP- and miRNA-mediated control of the
expression of this futsch reporter at this point in time.
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FIGURE 15. RNAi reduces the expression of FMRP in S2 cells. Introduction of
double stranded RNA that is complementary to the coding sequence of dFMR1 reduces
expression of FMR1 by 58% in S2 cells.
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FIGURE 16. Knock-down of FMRP does not change levels of futsch reporter
expression. S2 cells were transfected with a mixture of the F-Luc reporter plasmid, the
Renilla luciferase transfection control plasmid, and dFMR1 dsRNA. Firefly luciferase
activity was normalized to that of Renilla luciferase. Mean values ± standard error from
three biological replicates.
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Chapter Four: Discussion
4.1 In silico Analysis Shows That There Are Predicted Binding Sites for miRNAs in
the futsch 3’UTR
The miRNAs revealed by our in silico analysis are interesting for several reasons.
Notably, the sequence of Drosophila miR-9a is perfectly identical to human miR-9_1,
and each targets Futsch/MAP1B respectively (TargetScanFly5.2; TargetScanHuman 5.2
(miRBase; http://www.targetscanmirbase.org; Friedman, et al., 2009; Grimson, et al.,
2007; Lewis, et al., 2005). Moreover, murine miR-9 has been shown to co-immunopurify
with FMRP and is involved in the control of synapse structure (Edbauer et al., 2010).
Together, these data suggest that miR-9a is a strong candidate for co-regulation of
FMRP-mediated control of MAP1B/Futsch expression. Second, miR-963 and miR-976
are predicted to bind to futsch 3’UTR, but are not expressed in the larval CNS (Figure 8;
Appendix A). Because they are not expressed in the larval CNS, we have chosen not to
pursue them as potential regulatory factors in larval synapse function. However, it would
be very interesting to see if they are involved in the control of futsch expression at
embryonic or adult stages of development.

4.2 miR-315 and the miR-9 Family are Expressed in the Drosophila CNS
Both the miRNA microarray and qRT-PCR demonstrate that our miRNAs of
interest are expressed in the Drosophila larval CNS. The binding sites of the miRNAs we
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have chosen to pursue (the miR-9 family and miR-315) have important properties. In
order for a miRNA to recognize and bind its target, a specific portion of the miRNA
known as the seed region (underlined in Figure 17) must match the target mRNAs 3’UTR
with perfect complementation. Our in silico analysis showed the miR-9 family and miR315 seed regions to potentially bind to the futsch mRNA. Interestingly, the predicted
binding sites for the miR-9 family and miR-315 partially overlap. There are several
implications to these observations. First, the binding sites for each of these miRNAs are
mutually exclusive. For example, a miR-9a containing RISC cannot physically occupy
the same site as a miR-315 containing RISC. It is unclear what the implications of this
would be on futsch regulation. Second, the seed regions for the miR-9 family and miR315 overlap by a single nucleotide. This raises the possibility that the FLuc9mut reporter
plasmid may also disrupt regulation by miR-315. Finally, the presence of a second
poorly conserved miR-315 binding site (found in Drosophila melanogaster) raises the
possibility that futsch may be coordinately regulated by multiple miR-315 containing
RISCs. Perhaps this is why the repression of the futsch reporter upon co-expression of
miR-315 with the wild type FLuc-F reporter is more robust than any member of the miR9 family (Figure 9).

4.3 miR-315 and the miR-9 Family Specifically Repress the Expression of futsch
While in silico analysis is a powerful tool, even with a perfect seed region match,
the miR-9 family and miR-315 interaction with futsch is merely a prediction and requires
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FIGURE 17. The miRNA (miR-9a, miR-9b, miR-9c (the “miR-9 family”), and miR315) binding sites on the futsch 3’UTR. (As predicted by TargetScanFly algorithm
(http://www.targetscan.org; Release 5.1 Friedman, et al., 2009; Grimson, et al., 2007;
Lewis et al., 2005) and the sequences of the miRNAs which we decided to investigate.
The underlined sequences indicate the miRNA seed regions.
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validation. It is not unprecedented for predicted binding partners to have no interaction
in vivo.

Using the S2 luciferase reporter system, we were able to conclusively

demonstrate that our miRNAs of interest actually down-regulate expression of our futsch
reporter (Figure 10). We found that the site-directed mutagenesis of the futsch 3’UTR
binding sites for our miRNAs of interest relieve the repression caused by miRNA overexpression, though to different extents. Again, a possible explanation for the observation
that miR-315 has the strongest repression effect is that there are two miR-315 binding
sites on the futsch 3’UTR compared to the miR-9 family, which each have only one. We
only mutated the miR-315 site that has the highest predicted binding potential. It would
be interesting to mutate the second site to see if it changes reporter levels. Also, the
TargetScanFly algorithm (http://www.targetscan.org; Release 5.1 Friedman, et al., 2009;
Grimson et al., 2007; Lewis et al., 2005) predicts the miR-315 binding interaction to be
especially strong because it has a precise 8 base pair match to the futsch 3’UTR mRNA,
as opposed to the perfect 7 base pair match for the miR-9 family miRNAs.
4.4 Unexpected Findings:

miRNAs miR-9a and miR-9c Can Up-regulate the

Translation of a Mutagenized futsch Reporter
Our primary goal in conducting the site-directed mutagenesis experiments was to
demonstrate that the reduction in F-Luc observed upon miRNA over-expression was
specifically due to an interaction at the miRNA core binding site. The site-directed
mutagenesis experiments clearly show that this is the case.
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Unexpectedly, in the case of miR-9a and miR-9c, we observed that miRNA overexpression actually increased the mutated F-Luc reporter expression above the levels of
the mutated reporter without miRNA over-expression. We had expected site-directed
mutation of the reporter to relieve the down-regulation caused by miRNA overexpression, but it appears that in some cases miRNA over-expression actually enhances
mutated reporter expression. We theorize that this unexpected observation of increase in
translation in the mutated futsch reporter plasmid upon over-expression of a miRNA
might represent a novel regulatory mechanism. Perhaps miR-9a and -9c are negative
regulators of futsch and some other protein which itself regulates Futsch. These two
miRNAs share nearly 100% sequence identity outside of the seed region while miR-9b is
considerably more divergent (Figure 17). One interesting possibility based on in silico
data from TargetScanFly suggests that FMRP itself could be this protein. FMRP is
predicted to be a very strong candidate for regulation by both miR-9a and -9c. Based on
this observation, we propose the following working model (Figure 18). In this model,
miRNAs independently down-regulate expression of Futsch and FMRP. Our data are
consistent with this model. If we increase miRNA expression while blocking their
binding to futsch 3’UTR, it would follow that the repression of FMRP would continue.
The repression of FMRP, itself a repressor of futsch, would result in an increase in futsch
expression.
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FIGURE 18. Model for miRNA repression of Futsch and FMRP. We have found that
miRNA over-expression down-regulates futsch expression. We have observed that overexpression of miRNAs sometimes increases expression of the futsch reporter in which the
miRNA binding site has been mutated. A possible model to explain this phenomenon is
that miRNA over-expression (specifically miR-9a and -9c) down-regulates another
protein (perhaps FMRP) which itself is a negative regulator of futsch.
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4.5 Down-Regulation of FMRP Does Not Increase Expression of the futsch Reporter
It has been demonstrated that FMRP is a negative regulator of futsch (Zhang et
al., 2001). It follows that down-regulation of FMRP would result in higher levels of
futsch expression. Thus, we hypothesized that we would observe increased levels of our
futsch reporter with our (successful) down-regulation of FMRP by RNAi. Interestingly,
we did not find this to be the case (Figure 16). We did not observe any significant
change in the levels of expression of the futsch reporter. There are several explanations
for this observation. First, it could be that the pathway by which these phenomena occur
is more complicated than what has been predicted, thus down-regulation of FMRP in
isolation from the rest of the system does not result in lower levels of futsch expression.
Another possibility is that FMRP down-regulates expression of futsch via a direct
interaction, but not through the 3’UTR mRNA region. Our reporter is only sensitive to
effects of 3’UTR futsch regulation. If FMRP down regulates futsch by interacting with a
different portion of the futsch mRNA (perhaps the 5’UTR or the coding sequence), levels
of our reporter would not be affected by FMRP knock-down, as our reporter only
contains the 3’UTR of the futsch gene. A third possibility is that partial knockdown of
FMRP is not sufficient to down- regulate futsch expression. It is unknown whether or not
heterozygous null FMRP flies have normal futsch expression levels. We were not able to
prove or disprove the hypothesis, but our experiments suggest a potential model for the
regulation of Futsch expression that we had not considered.
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4.6 Potential Caveats
In closing, one important fact to consider in the interpretation of all of our dualluciferase results is that the firefly luciferase reporter indicates what Futsch levels should
be, but does not actually measure endogenous changes in expression of the Futsch
protein.

The firefly luciferase reporter is under the control of putative regulatory

elements in the futsch 3’UTR, but is not connected to the actual Futsch protein.
Therefore, this reporter system has an additional caveat in that the reporter is only
sensitive to regulation imposed on the 3’UTR of futsch. In reality, Futsch may be under
regulation of many factors (perhaps including FMRP) due to interactions with the coding
sequence or 5’UTR of the futsch mRNA.

4.7 Potential Future Directions
miRNAs are believed to bind to and target mRNAs for either mRNA decay or
translational repression.

We were not able to conclude whether RNA stability (or

instability) is the cause of observed changes in expression, as opposed to translational
repression. To test this, we could perform qRT-PCR on the S2 cell lysates to determine if
the levels of futsch mRNA are reduced upon over-expression. A finding that futsch
mRNA levels are lower after over-expression of miRNAs would indicate that the
miRNAs are targeting the futsch mRNA for degradation. If futsch mRNA levels were not
changed by miRNA over-expression, it would indicate that the miRNAs are repressing
the translation of Futsch, but that the futsch mRNA remains intact.
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There are several additional steps that could be taken to address our unanswered
hypothesis. It is possible that we might observe a change in futsch reporter expression if
we were able to achieve a complete FMRP knock down, vs. the 58% knock-down we
observed. It is possible that a longer incubation of the S2 cells (on the order of a week or
more) or repeated applications of dFMR1 dsRNA might achieve a greater or even
complete reduction of FMRP expression, and perhaps an observable change in our futsch
reporter levels. Further, it is possible that dFMR1 dsRNA complementary to a different
portion of the dFMR1 gene might provide more effective repression.
Another option is to perform essentially the opposite experiment: co-express the
futsch reporter plasmid with a plasmid that over-expresses FMRP. If we still did not
observe any change in futsch reporter levels, we would have additional evidence
indicating FMRP is not involved in regulating futsch (at least via the 3’UTR). We could
investigate the possibility that FMRP regulates futsch via a sequence not in the 3’UTR by
creating a reporter under the control of a 5’regulatory sequence.
It would also be interesting to perform genetic epistasis experiments between
miRNA and FMRP in S2 cells. We could perform the experiment shown in figure 9
while knocking-down FMR1. If we could accomplish a 100% knock-down of FMR1,
and we observed identical repression of the futsch reporter, that would provide additional
evidence that miRNAs regulate futsch independently of FMRP.
Finally, we have produced fly lines that over-express the miRNAs -9a, -9b, -9c
and -315 with which we could perform many in vivo assays, including, but not limited to,
genetic interactions affecting NMJ synaptic structure and development.
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miRNAs could play an important role in long-term synaptic plasticity underlying
learning and memory as well as in dynamic regulation of synaptic protein synthesis in
response to activation of neurotransmitter receptors, such as mGluRs (Muddashetty et al.
2011).

It has been theorized that exaggerated protein synthesis (due to the lack of the

protein synthesis inhibitor, FMRP) downstream of the mGluRs is a main cause of FXS
pathology (Krueger and Bear, 2011). While a treatment that blocks mGluR stimulation
could potentially alleviate the symptoms of FXS (Figure 19), it would likely create many
unintended side effects because the mGluR regulatory system affects a diverse array of
functions.
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FIGURE 19.
Model of FXS pathogenesis and potential pharmacological
interventions. The activation of mGluR receptors stimulates translation of mRNAs at
the synapse. Normally, FMRP represses translation of those mRNAs. In absence of
FMRP, the mRNAs are over-expressed, which may cause pathology. Pharmacological
interventions that block mGluR stimulation may alleviate FXS pathology. Figure
adapted from Penagarikano et al., 2007.
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Chapter Five: Summary
We have hypothesized that FMRP and miRNAs co-regulate expression of futsch
(the Drosophila homologue of MAP1B). Using an in vitro luciferase reporter system, we
have shown that miR-315 and members of the miR-9 family selectively down-regulate
futsch reporter translation. We have confirmed by site-directed mutagenesis that the
miRNA interaction with the futsch 3’UTR is specific to the miRNA seed region binding
site. Reporter plasmids with mutated miRNA binding sites did not display downregulation upon over-expression of the applicable miRNAs. These data strongly suggest
that miRNAs-9a/b/c and -315 regulate futsch. We have not been able to determine
whether or not miRNAs and FMRP co-regulate futsch. The course of our experiments
however, has suggested potential previously unknown regulatory mechanisms.
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Appendix A
Drosophila melanogaster 3rd Instar Larval CNS Specific miRNAs

APPENDIX 1. 79 miRNAs are expressed in the Drosophila melanogaster 3rd instar
larval CNS as identified by miRNA microarray analysis (Exiqon). The database used
to construct the profile above covered 62% of miRNAs currently known to be present in
Drosophila melanogaster (miRBase 17.0). However, at the time that the array was
performed, our results covered 99.3% of known miRNAs (miRBase 14.0). Analysis was
conducted in collaboration with Robert Sand.
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Appendix B
List of abbreviations/definitions

CNS = Central Nervous System
dFMR1 = Drosophila FMR1
FMRP = Fragile X mental retardation protein
FMR1 = fragile X mental retardation 1, the gene responsible for FXS.
FXPOI = fragile X-associated premature ovarian failure
FXS = Fragile X syndrome
FXTAS = fragile X-associated tremor ataxia syndrome
MAP1B = microtubule associated protein 1B, the mammalian homolog of Futsch
miRISC = miRNA-containing RISC
miRNA = microRNAs
NMJ = Neuromuscular Junction
RISC = RNA-Induced Silencing Complex
RNAi = RNA interference
qRT-PCR = quantitative real-time PCR
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